However, a growing body of research has established the role of GSK-3β as a protooncogenic protein itself, particularly in the context of ovarian cancer, acute leukemias, glioblastoma, neuroblastoma, and PDAC [11,12,13,14]. Here, GSK3B is linked to glioblastoma.